1
|
Abstract
Aspirin has become a widely accepted platelet function inhibitor and is used to prevent arterial occlusions in coronary cerebral and peripheral vascular disease. The results of clinical studies with aspirin in the area of peripheral arterial occlusive disease are critically reviewed. Two thienopyridine compounds, ticlopidine and clopidogrel, have been effectively used in the prevention of myocardial infarction and stroke in several clinical trials, especially in the recently published CAPRIE-trial. Potent new platelet function inhibitors recently were developed. Intravenous treatment with abciximab, a new platelet membrane glycoprotein IIb/IIIa-inhibitor, effectively prevented coronary reocclusions in patients with high-risk coronary events. A series of promising new oral IIb/IIIa- inhibitors have been developed and may become effective drugs in the prevention of reocclusions in patients with periph eral vascular disease and in coronary or cerebral vascular dis ease. Key Words: Antiplatelet agents—Aspirin—Peripheral arterial disease—Ticlopidine—Clopidogrel—GPIIb/IIIa inhibitor.
Collapse
Affiliation(s)
- Hans Klaus Breddin
- International Institute of Thrombosis and Vascular Diseases, Frankfurt, Germany
| |
Collapse
|
2
|
Potassium concentration on admission is an independent risk factor for target lesion revascularization in acute myocardial infarction. ScientificWorldJournal 2014; 2014:946803. [PMID: 24523655 PMCID: PMC3913530 DOI: 10.1155/2014/946803] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2013] [Accepted: 10/22/2013] [Indexed: 01/10/2023] Open
Abstract
Background. Acute myocardial infarction (AMI) is accompanied by excessive production of catecholamines, which is characterized by a hypokalemic dip.
A polymorphism of the adrenergic receptor has also been reported to be associated with target lesion revascularization (TLR) after coronary intervention.
Subjects and Methods. We enrolled 276 consecutive patients with AMI within 24 hours of symptom onset, who underwent emergency coronary intervention
using bare metal stents and had examinations over a 5–10-month follow-up period. The patients were divided into tertiles based on their serum potassium level on admission
(low K, <3.9; mid K, ≥3.9, <4.3; and high K, ≥4.3). Results. Sixty-four TLRs were observed in the study.
Increased potassium concentration was associated significantly with TLR. Patients in the high K group were about two and a half times more likely to have a TLR after AMI compared to
those in the low K group. Multiple logistic analysis showed that potassium level on admission was an independent risk factor for TLR (odds ratio 1.69; confidence interval 1.04 to 2.74; P = 0.036). Conclusions. These findings indicated that increased potassium levels on admission might predict TLRs in AMI patients treated with bare metal stents.
Collapse
|
3
|
Abstract
Stenting in acute myocardial infarction (AMI) has the benefits of achieving acute optimal angiographic results and correcting residual dissection to decrease the incidence of restenosis and reocclusion. Studies have shown that percutaneous transluminal coronary angioplasty for primary treatment after AMI is superior to thrombolytic therapy regarding the restoration of normal coronary blood flow. Coronary stenting improves initial success rates, decreases the incidence of abrupt closure, and is associated with a reduced rate of restenosis. In the presence of thrombus-containing lesions, coronary stenting constitutes an effective therapeutic strategy, either after failure of initial angioplasty or electively as the primary procedure.
Collapse
Affiliation(s)
- Ahmed Magdy
- Cardiology Department, National Heart Institute, 44 Alsharifa Dina, Maadi, Cairo 11431, Egypt.
| | - Hisham Selim
- Cardiology Department, National Heart Institute, 44 Alsharifa Dina, Maadi, Cairo 11431, Egypt
| | - Mona Youssef
- Cardiology Department, National Heart Institute, 44 Alsharifa Dina, Maadi, Cairo 11431, Egypt
| |
Collapse
|
4
|
Ormiston JA, Abizaid A, Spertus J, Fajadet J, Mauri L, Schofer J, Verheye S, Dens J, Thuesen L, Dubois C, Hoffmann R, Wijns W, Fitzgerald PJ, Popma JJ, Macours N, Cebrian A, Stoll HP, Rogers C, Spaulding C. Six-Month Results of the NEVO RES-ELUTION I (NEVO RES-I) Trial. Circ Cardiovasc Interv 2010; 3:556-64. [DOI: 10.1161/circinterventions.110.946426] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background—
Drug-eluting stents reduce restenosis and reintervention rates but are complicated by stent thrombosis, which may be related to polymer coating. The NEVO sirolimus-eluting coronary stent (NEVO SES) is designed to improve long-term percutaneous coronary intervention safety by combining sirolimus release from reservoirs with bioabsorbable polymer to reduce spatial and temporal polymer exposure.
Methods and Results—
NEVO ResElution-I was a prospective randomized study in 394 patients with coronary artery disease comparing the NEVO SES with the TAXUS Liberté paclitaxel-eluting coronary stent (TAXUS Liberté PES) stent. The primary end point was in-stent angiographic late loss at 6 months. Six months after percutaneous coronary intervention (PCI), the primary end point favored NEVO SES (0.13±0.31 mm versus 0.36±0.48 mm,
P
<0.001 for noninferiority and superiority). The study was not powered for clinical end points and showed no significant difference for NEVO SES versus TAXUS Liberté PES: death: 0.5 versus 1.6%,
P
=0.36; myocardial infarction: 2.0 versus 2.6%,
P
=0.75; target lesion revascularization: 1.5 versus 3.2%,
P
=0.33; major adverse cardiac events: 4.0 versus 7.4%,
P
=0.19. No stent thrombosis was observed with NEVO SES, whereas 2 cases occurred in TAXUS Liberté PES. Intravascular ultrasound showed lower percent volume obstruction for NEVO SES (5.5±11% versus 11.5±9.7%,
P
=0.016).
Conclusions—
This trial proved the superiority of NEVO SES over TAXUS Liberté PES for the primary angiographic end point of in-stent late loss. No stent thrombosis occurred in the NEVO SES group.
Clinical Trial Registration—
URL:
http://www.clinicaltrials.gov
. Unique identifier: NCT00606333.
Collapse
Affiliation(s)
- John A. Ormiston
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Alexandre Abizaid
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - John Spertus
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Jean Fajadet
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Laura Mauri
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Joachim Schofer
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Stefan Verheye
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Joseph Dens
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Leif Thuesen
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Christophe Dubois
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Rainer Hoffmann
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - William Wijns
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Peter J. Fitzgerald
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Jeffrey J. Popma
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Nathalie Macours
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Ana Cebrian
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Hans-Peter Stoll
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Campbell Rogers
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | - Christian Spaulding
- From the North Shore Hospital (J.O.), Auckland, New Zealand; Instituto Dante Pazzanese (A.A.), Sao Paolo, Brazil; St Luke's Hospital (J. Spertus), Kansas City, Mo; Clinique Pasteur (J.F.), Toulouse, France; Brigham and Women's Hospital (L.M.), Boston, Mass; Herzkatheterlabor und Praxisklinik (J. Schofer), Hamburg, Germany; Middelheim Hospital (S.V.), Antwerp, Belgium; Ziekenhuis Oost-Limburg (J.D.), Genk, Belgium; Skejby Sygehus (L.T.), Aarhus, Denmark; University Hospital (C.D.), Leuven, Belgium
| | | |
Collapse
|
5
|
Abstract
The acute coronary syndrome comprises unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction. A successful and stable revascularisation of the infarct related vessel, and the prevention of the loss of myocardium are the main therapeutic targets, as cardiovascular mortality and long term quality of life are essentially determined by left ventricular function. The clinical diagnosis comprises clinical symptoms, ECG-changes, and cardiac troponins. Early percutaneous coronary intervention (PCI) has become the most common method of coronary revascularisation. If PCI is not available, systemic thrombolysis is an alternative after exclusion of contraindications. Parenteral anticoagulation with intravenous or subcutaneous heparines, antithrombotic therapy and HMG-CoA reductase inhibitors are the common secondary drug therapy. Moreover, to prevent left ventricular remodelling ACE-inhibitors, angiotension 2-receptor antagonists, and beta-blocker are indicated.
Collapse
Affiliation(s)
- M Kelm
- Klinik für Kardiologie, Pneumologie und Angiologie, Medizinische Klinik und Poliklinik B, Heinrich-Heine-Universität Düsseldorf.
| | | |
Collapse
|
6
|
Takasaki K, Otsuji Y, Yoshifuku S, Kuwahara E, Yuasa T, Abd-El-Rahim AER, Matsukida K, Kumanohoso T, Toyonaga K, Kisanuki A, Minagoe S, Tei C. Noninvasive estimation of impaired hemodynamics for patients with acute myocardial infarction by Tei index. J Am Soc Echocardiogr 2004; 17:615-21. [PMID: 15163931 DOI: 10.1016/j.echo.2004.02.020] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
BACKGROUND Tei index, defined as the sum of isovolumic contraction and relaxation times divided by ejection time, has been proposed to express global left ventricular function. For patients with acute myocardial infarction (AMI), left ventricular function can potentially be a major determinant of hemodynamics with limited time for compensation, such as increased brain natriuretic peptide to attenuate congestion, and usually without any intervention to modify cardiac loading on arrival at the hospital during the acute phase. We, therefore, hypothesized that left ventricular function, expressed by the Tei index, allows noninvasive estimation of impaired hemodynamics for patients with AMI. METHODS We studied 86 consecutive patients with first AMI (34 inferoposterior and 52 anteroseptal). Tei index was obtained as: (a - b)/b, where a is the interval between the cessation and onset of mitral flow and b is the ejection time by aortic flow by pulsed Doppler echocardiography. By using pulmonary capillary wedge pressure (PCWP) > or = 18 mm Hg or <18 mm Hg and cardiac index (CI) < or = 2.2 L/min/m(2) or > 2.2 L/min/m(2) by consecutive catheterization, patients were classified into 4 subsets: subset I with normal hemodynamics; subset II with elevated PCWP; subset III with reduced CI; and subset IV with both elevated PCWP and reduced CI. RESULTS For patients with inferoposterior AMI, there was no significant correlation between the Tei index and PCWP or CI. For patients with anteroseptal AMI, however, the Tei index showed significant correlation both with PCWP (r = 0.59, P <.0001) and CI (r = -0.42, P <.01). Diagnosis of impaired hemodynamics (subset II-IV) by a Tei index > or = 0.60 showed a sensitivity, specificity, and accuracy of 86%, 82%, and 83%, respectively. CONCLUSIONS Although the Tei index has limitations to evaluate hemodynamics in patients with inferoposterior AMI, the index allows approximate but quick and practical noninvasive estimation of impaired hemodynamics in patients with anteroseptal AMI.
Collapse
Affiliation(s)
- Kunitsugu Takasaki
- First Department of Internal Medicine, Kagoshima University School of Medicine, and Division of Cardiology, Kagoshima City Hospital, Sakuragaoka, Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Tariq M, Carroll R, Zabih I, Stenberg RG, Hussain KMA. Emergency coronary stenting for complete thrombotic occlusion of an unprotected left main coronary artery in acute myocardial infarction complicated by cardiogenic shock in an octogenarian patient--a case report. Angiology 2002; 53:95-8. [PMID: 11865840 DOI: 10.1177/000331970205300113] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
This report concerns an 82-year-old white man, who was admitted with cardiogenic shock secondary to an acute anterior myocardial infarction with right bundle branch block requiring an intra-aortic balloon pump for hemodynamic support and mechanical ventilatory support for respiratory distress. An immediate cardiac catheterization with coronary angiography revealed a complete thrombotic occlusion of the left main coronary artery. Prompt stent-supported percutaneous transluminal coronary angioplasty to the occluded left main coronary artery, a critical stenosis of the ostial left anterior descending artery, and the left circumflex coronary artery, allowed for recovery from this life-threatening condition and subsequent discharge from the hospital of this octogenarian patient. It is suggested that in a critical clinical condition with particularly challenging coronary anatomical findings, stent-supported coronary angioplasty can be lifesaving treatment in selected patients with octogenarian status with acute myocardial infarction.
Collapse
Affiliation(s)
- M Tariq
- Department of Medicine, Conemaugh Memorial Medical Center, Johnstown, PA 15905, USA
| | | | | | | | | |
Collapse
|
8
|
Galli M, Sommariva L, Prati F, Zerboni S, Politi A, Bonatti R, Mameli S, Butti E, Pagano A, Ferrari G. Acute and mid-term results of phosphorylcholine-coated stents in primary coronary stenting for acute myocardial infarction. Catheter Cardiovasc Interv 2001; 53:182-7. [PMID: 11387601 DOI: 10.1002/ccd.1145] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The aim of this pilot study was to evaluate the safety and efficacy of the BiodivYsio phosphorylcholine-coated stent in the primary treatment of acute myocardial infarction. The BiodivYsio stent (Biocompatible) is a balloon-expandable stent, laser etched from a 316 L stainless steel tube. This device is coated with phosphorylcholine, a synthetic, hemocompatible phospholipid polymer that has been shown in experimental studies to reduce platelet and protein adhesion to the surface of the metal. One hundred consecutive patients within 24 hr of symptoms of onset of acute MI, treated with primary PTCA, were enrolled. After PTCA, stenting was attempted in all eligible lesions (reference diameter > or = 2.5 mm; no bend lesion > 45 degrees ). Poststenting regimens contained ticlopidine (500 mg/day) and aspirin (325 mg/day) and 6-12 hr of heparin infusion. Procedural success (TIMI > or = II and residual stenosis < 30%) was obtained in 70/74 cases (95%). TIMI grade III was restored in 90% of cases. In the patient group with procedural success (70 cases), 70 BiodivYsio stents were placed. After stenting, diameter stenosis decreased from 96% +/- 11% to 22% +/- 12% (P < 0.01) and minimal luminal diameter increased from 0.13 +/- 0.29 to 2.47 +/- 0.43 (P < 0.01). Nominal stent diameter was between 3.0 and 4.0 mm (mean, 3.5 +/- 0.4 mm). Stent length was between 11 and 28 mm (mean, 17 +/- 4.5 mm). Clinical follow-up was obtained in all patients; angiographic follow-up was performed in 65/70 (93%). No acute or subacute thrombosis was reported. Two in-hospital major adverse cardiac events (MACE) were reported due to a nontreated left main disease that required coronary artery bypass graft (CABG) surgery. At follow-up, MACE were found in 9 of 68 patients (13%), target lesion revascularization (TLR) in 6%, and CABG in the remaining 6%. Primary stenting with phosphorylcholine-coated stent leads to excellent short- and mid-term clinical outcomes and is associated with a restenosis rate of 12%.
Collapse
Affiliation(s)
- M Galli
- Catheterization Laboratory, Cardiology Department, S. Anna Hospital, Como, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Yamada T, Nakagawa Y, Hamasaki N, Nobuyoshi M. Usefulness of intracoronary angioscopy for elucidating the cause of subacute thrombosis after stenting. JAPANESE CIRCULATION JOURNAL 2001; 65:232-5. [PMID: 11266200 DOI: 10.1253/jcj.65.232] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Stent thrombosis is rare with anti-platelet therapy, which consists of aspirin and ticlopidine as a post-stenting administration. A 77-year-old man had repeated stent thrombosis, which was not predicted by coronary angiography, despite using contemporary periprocedural anti-platelet therapy. Only intravascular fiberscopy was able to detect the cause of the stent thrombosis.
Collapse
Affiliation(s)
- T Yamada
- Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan
| | | | | | | |
Collapse
|
10
|
Santoro GM, Bolognese L. Coronary stenting and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction. Am Heart J 2001; 141:S26-35. [PMID: 11174356 DOI: 10.1067/mhj.2001.109953] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
BACKGROUND Myocardial reperfusion in patients with acute myocardial infarction may be successfully achieved with primary angioplasty. However, angioplasty, as a primary reperfusion strategy, has limitations such as early recurrent ischemia and late restenosis and reocclusion. To improve the short- and long-term results of primary angioplasty, the use of adjunct strategies has been proposed. METHODS We reviewed published studies on the effectiveness of primary angioplasty, stenting, and platelet glycoprotein IIb/IIIa receptor blockade and identified the advantages and disadvantages of these interventions in patients with acute myocardial infarction. RESULTS Recent findings suggest that patients may benefit from stenting of the infarct artery and from the use of more potent antiplatelet agents such as platelet glycoprotein IIb/IIIa receptor inhibitors. In randomized trials that compared primary angioplasty versus primary stenting, stent implantation was associated with a lower rate of death, reinfarction, and especially target vessel revascularization. Platelet glycoprotein IIb/IIIa receptor inhibitors prevented acute ischemic complications after primary angioplasty and primary stenting. In addition to maintaining large vessel patency, these drugs may protect the microvasculature after primary stenting, allowing better functional recovery of the risk area. CONCLUSIONS Coronary artery stenting in acute myocardial infarction reduces the rate of restenosis and the incidence of problems related to recurrent ischemia. Platelet glycoprotein IIb/IIIa receptor inhibitors may come to play a key role in association with mechanical reperfusion. However, the cost-effectiveness and long-term clinical outcome of this combined pharmacologic/mechanical intervention require further study before this strategy can be recommended for routine use.
Collapse
Affiliation(s)
- G M Santoro
- Division of Cardiology, Careggi Hospital, Florence, Italy.
| | | |
Collapse
|
11
|
Sasao H, Tsuchihashi K, Hase M, Nakata T, Shimamoto K. Does primary stenting preserve cardiac function in myocardial infarction? A case-control study. NORTH-981 investigators. Network of revascularisation therapy in Hokkaido. Heart 2000; 84:515-21. [PMID: 11040013 PMCID: PMC1729472 DOI: 10.1136/heart.84.5.515] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
OBJECTIVE To investigate whether coronary stenting limits myocardial injury and preserves left ventricular function. DESIGN AND SETTING Prospective multicentre case-control study of primary percutaneous transluminal coronary angioplasty (PTCA) with and without stenting, performed in seven cardiovascular centres. SUBJECTS AND METHODS 45 consecutive patients with acute myocardial infarction who were treated with successful primary stenting (Stent group) and did not have restenosis were paired with 45 matched control subjects with acute myocardial infarction treated by successful primary PTCA without stenting, also with no restenosis (POBA group). RESULTS In comparison with the POBA group, the Stent group-especially those patients with a left anterior descending coronary artery lesion-had a smaller hypokinesis area (mean (SD): 15. 1 (20.0) v 34.4 (24.3) chords), reduced hypokinesis area/risk area (25.2 (31.9)% v 58.8 (40.1)%), and a larger ejection fraction (63.3 (10.2)% v 51.7 (11.7)%) evaluated by quantitative left ventriculography using the centerline method. In the Stent group, the correlation between risk area and hypokinesis area was significantly shifted downward. Multiple logistic regression analysis on infarct size limitation (hypokinesis area/risk area < 50%) identified preinfarction angina in all subjects and preinfarction angina and stenting in patients with left anterior descending coronary artery lesions as explanatory factors. CONCLUSIONS Primary PTCA using a coronary stent is effective in preventing myocardial injury and restoring left ventricular function in patients with anterior acute myocardial infarction.
Collapse
Affiliation(s)
- H Sasao
- Second Department of Internal Medicine, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-ku, Sapporo 060-0061, Japan.
| | | | | | | | | |
Collapse
|
12
|
Abstract
Stenting lesions with favorable characteristics as required for inclusion in the STRESS/BENESTENT trials have yielded superior results to that of PTCA alone. Results for less favorable lesions such as in small vessels, diffuse disease, ostial disease, and saphenous vein grafts are less well established. This review seeks to analyze available data for stent placement in this subset of non-STRESS/BENESTENT lesions.
Collapse
Affiliation(s)
- P Wong
- Department of Cardiology, National Heart Center, Singapore.
| | | | | | | |
Collapse
|
13
|
Fabbiocchi F, Bartorelli AL, Montorsi P, Cozzi S, Trabattoni D, Calligaris G, Loaldi A. Elective coronary stent implantation in cardiogenic shock complicating acute myocardial infarction: in-hospital and six-month clinical and angiographic results. Catheter Cardiovasc Interv 2000; 50:384-9. [PMID: 10931605 DOI: 10.1002/1522-726x(200008)50:4<384::aid-ccd3>3.0.co;2-k] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Effective treatment of patients with acute myocardial infarction and cardiogenic shock depends on restoring persistent patency of the infarct-related artery. Coronary stenting, reducing abrupt or delayed closure related to dissection and suboptimal result, may improve PTCA results in cardiogenic shock. Eighteen patients (14 males and 4 females, mean age 59 +/- 7 years), referred to catheterization laboratory for acute myocardial infarction and shock, had elective stent implantation during 14 primary and 4 rescue PTCA. Time delay between shock onset and PTCA was 4.1 +/- 3 hr (range, 30 min to 12 hr). The IRA was LAD in seven patients (38%), LCx in two (11%), and RCA in eight (45%). One patient (5.%) had distal LMCA occlusion. Stent deployment was successful in 100% of patients and resulted in TIMI 3 flow in 13 (72%) patients. In 13 (72%) cases, cardiogenic shock gradually resolved and the patients were discharged alive. Five patients (28%) died because of irreversible hemodynamic deterioration without evidence of reinfarction. At 6-month follow-up, all the discharged patients were alive and no patient had reinfarction or recurrent angina. Heart transplant was required in one patient 5 months after stenting because of refractory congestive heart failure. Angiography demonstrated patency of all the coronary arteries treated, with TIMI 3 flow in all patients. Stent restenosis rate was 30%, and target lesion revascularization with CABG or re-PTCA was not required in any case. LV function improved from 39% +/- 15% to 51% +/- 15% (P < 0.01). Elective coronary stenting is an effective treatment for acute myocardial infarction complicated by cardiogenic shock and may improve acute and long-term survival.
Collapse
Affiliation(s)
- F Fabbiocchi
- Institute of Cardiology, University of Milan, Fondazione "Monzino" Italy.
| | | | | | | | | | | | | |
Collapse
|
14
|
Maillard L, Hamon M, Khalife K, Steg PG, Beygui F, Guermonprez JL, Spaulding CM, Boulenc JM, Lipiecki J, Lafont A, Brunel P, Grollier G, Koning R, Coste P, Favereau X, Lancelin B, Van Belle E, Serruys P, Monassier JP, Raynaud P. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators. J Am Coll Cardiol 2000; 35:1729-36. [PMID: 10841218 DOI: 10.1016/s0735-1097(00)00612-4] [Citation(s) in RCA: 112] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
OBJECTIVES In a multicenter, randomized trial, systematic stenting using the Wiktor stent was compared to conventional balloon angioplasty with provisional stenting for the treatment of acute myocardial infarction (AMI). BACKGROUND Primary angioplasty in AMI is limited by in-hospital recurrent ischemia and a high restenosis rate. METHODS A total of 211 patients with AMI <12 h from symptom onset, with an occluded native coronary artery, were randomly assigned to systematic stenting (n = 101) or balloon angioplasty (n = 110). The primary end point was the binary six-month restenosis rate determined by core laboratory quantitative angiographic analysis. RESULTS Angiographic success (Thrombolysis in Myocardial Infarction [TIMI] flow grade 3 and residual diameter stenosis <50%) was achieved in 86% of the patients in the stent group and in 82.7% of those in the balloon angioplasty group (p = 0.5). Compared with the 3% cross-over in the stent group, cross-over to stenting was required in 36.4% of patients in the balloon angioplasty group (p = 0.0001). Six-month binary restenosis (> or = 50% residual stenosis) rates were 25.3% in the stent group and 39.6% in the balloon angioplasty group (p = 0.04). At six months, the event-free survival rates were 81.2% in the stent group and 72.7% in the balloon angioplasty group (p = 0.14), and the repeat revascularization rates were 16.8% and 26.4%, respectively (p = 0.1). At one year, the event-free survival rates were 80.2% in the stent group and 71.8% in the balloon angioplasty group (p = 0.16), and the repeat revascularization rates were 17.8% and 28.2%, respectively (p = 0.1). CONCLUSIONS In the setting of primary angioplasty for AMI, as compared with a strategy of conventional balloon angioplasty, systematic stenting using the Wiktor stent results in lower rates of angiographic restenosis.
Collapse
|
15
|
SCHUTTE DANIEL, POTGIETER LEONI, MOIR KERRYJ. Coronary Stenting Without Predilatation in Acute Coronary Syndromes. J Interv Cardiol 2000. [DOI: 10.1111/j.1540-8183.2000.tb00283.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
16
|
TORTOLEDO FRANCISCO, FERMÍN ENRIQUE, RODRÍGUEZ VÍCTOR, VÁSQUEZ JOSÉR. Coronary Pulsed-Spray: Accelerated Pharmacomechanical Intravascular Thrombolysis in Acute Coronary Events Followed by Immediate Endovascular Therapy. J Interv Cardiol 2000. [DOI: 10.1111/j.1540-8183.2000.tb00691.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
17
|
Affiliation(s)
- J S Kaufman
- Department of Medicine, VA Boston Healthcare System, MA 02130, USA.
| |
Collapse
|
18
|
Antoniucci D, Valenti R, Santoro GM, Bolognese L, Trapani M, Moschi G, Fazzini PF. Primary coronary infarct artery stenting in acute myocardial infarction. Am J Cardiol 1999; 84:505-10. [PMID: 10482145 DOI: 10.1016/s0002-9149(99)00367-7] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Completed and ongoing randomized trials have provided results that favor primary infarct-related artery (IRA) stenting as opposed to primary percutaneous transluminal coronary angioplasty, but the applicability of the trial results to all patients with acute myocardial infarction (AMI) has not yet been investigated. This study sought to determine the applicability of an unconditional IRA stenting strategy in nonselected patients with AMI. After successful mechanical recanalization of the IRA, all patients with AMI and a reference diameter > or =2.5 mm were considered eligible for primary IRA stenting without any restriction regarding age or clinical status on presentation. The primary end point of the study was a composite end point defined as death, reinfarction, or repeat target lesion revascularization. Primary IRA stenting was successfully performed in 161 of 190 consecutive patients with AMI (85%), and of 162 (99%) considered suitable for stenting. Patients with nonstented IRA had a reference IRA diameter smaller than patients with a stent (2.71+/-0.48 vs 3.20+/-0.41 mm, p <0.001). Overall, the 6-month mortality was 5%. Mortality was 2% for patients without, and 32% for patients with cardiogenic shock. The incidences of reinfarction and of repeat target lesion revascularization were 1% and 12%, respectively. The 6-month angiographic follow-up showed an IRA patency rate of 94% and a restenosis rate of 26%. The results of this study strengthen the hypothesis that unconditional primary IRA stenting is highly feasible, and may actually improve the outcome of patients with AMI.
Collapse
Affiliation(s)
- D Antoniucci
- Division of Cardiology, Careggi Hospital, Florence, Italy.
| | | | | | | | | | | | | |
Collapse
|
19
|
Abstract
Primary infarct artery stenting has the potential to advance treatment of acute myocardial infarction. The postulated mechanisms of the benefit of stenting in acute myocardial infarction are the achievement of an acute optimal angiographic result and correction of any residual dissection to decrease the incidence of early and late restenosis and reocclusion and of the correlated events such as fatal and nonfatal reinfarction and repeat target vessel revascularization for recurrent ischemia. The results of 5 completed randomized trials comparing primary stenting with primary percutaneous transluminal coronary angioplasty show a lower incidence of the composite end point of death, myocardial infarction, and repeat target vessel revascularization in the stent groups as compared with the angioplasty groups and support the more extensive use of stents in patients with acute myocardial infarction. The efforts of the next years will be focused on further refinement of stent design and composition and the evaluation of pharmacological agents effective in restoring myocardial reperfusion to the fullest extent.
Collapse
Affiliation(s)
- D Antoniucci
- Division of Cardiology, Careggi Hospital, Viale Morgagni, Florence, Italy
| | | | | | | |
Collapse
|
20
|
Chiou KR, Chou CY, Chan WL, Pan JP, Lin SJ, Charng MJ, Chen YH, Hsu NW, Wang SP, Ding PY, Chang MS. Results of coronary stenting after delayed angioplasty of the culprit vessel in patients with recent myocardial infarction. Catheter Cardiovasc Interv 1999; 47:423-9. [PMID: 10470471 DOI: 10.1002/(sici)1522-726x(199908)47:4<423::aid-ccd9>3.0.co;2-k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Little information is available concerning the effect of late coronary stenting in patients with recent myocardial infarction, especially long-term results. We retrospectively reviewed our results of 57 stent placements in 52 consecutive patients who received stents at an infarct-related lesion 24 hr to 30 days after an acute myocardial infarctions (median, 14 days). The average age was 67 years; 90% were male. Two patients who suffered from acute stent thrombosis received revascularization again and two early deaths were due to refractory cardiogenic shock before discharge. Mean patient clinical follow-up was 18.3 +/- 6.5 months. There were 1 subacute stent thrombosis, 1 cardiogenic death, and 10 patients (20.8%) in total suffering from angina class II to IV. Angiographic follow-up was performed in 36 patients (80%) at a mean of 7.5 +/- 3.1 months. Of these 36 patients, only 1 (3% of the total population undergoing follow-up angiography) had reocclusion at follow-up, but restenosis existed in 18 patients (50%). We conclude that there is still relatively high incidence of angiographic recurrence that is often silent in long-term follow-up, though the long-term result of late stenting in recent MI is low incidence of reocclusion.
Collapse
Affiliation(s)
- K R Chiou
- Department of Medicine, National Yang-Ming University, School of Medicine, Taiwan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Stähr P, Rupprecht HJ, Voigtländer T, Post F, Otto M, Erbel R, Meyer J. A new thrombectomy catheter device (AngioJet) for the disruption of thrombi: An in vitro study. Catheter Cardiovasc Interv 1999; 47:381-9. [PMID: 10402302 DOI: 10.1002/(sici)1522-726x(199907)47:3<381::aid-ccd29>3.0.co;2-#] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
In this study we examined a new thrombectomy catheter device. Different kinds of in vitro generated thrombi and cadaver thrombi were disrupted in test tubes. The mean disruption rate (and disruption time for 1 g of thrombus) was 225 +/- 65 mg/sec (5 +/- 2 sec) for whole-blood, 117 +/- 60 mg/sec (12 +/- 9 sec) for fibrin, 41 +/- 18 mg/sec (30 +/- 18 sec) for mixed, 70 +/- 42 mg/sec (17 +/- 5 sec) for unorganized, 45 +/- 8 mg/sec (22 +/- 4 sec) for partly, and 5 +/- 1 mg/sec (216 +/- 29 sec) for completely organized cadaver thrombi (P < 0.05). More than 99% of fragmented particles of whole-blood thrombi were 0-12 microm in diameter. The particle size of fibrin, mixed, and cadaver thrombi was similar, with 25%-40% of particles between 0-12 microm, 55%-71% >12-24 microm, and 2%-7% >24 microm. The device may be effectively used in the therapy of massive pulmonary embolism or acute peripheral and coronary artery syndromes when medical thrombolysis is contraindicated and organization of thrombus is absent. Further studies need to be performed to investigate the potential effects of particle microembolization. Cathet. Cardiovasc. Intervent. 47:381-389, 1999.
Collapse
Affiliation(s)
- P Stähr
- Second Medical Clinic, Johannes-Gutenberg-University, Mainz, Germany
| | | | | | | | | | | | | |
Collapse
|
22
|
Edep ME, Guarneri EM, Teirstein PS, Phillips PS, Brown DL. Differences in TIMI frame count following successful reperfusion with stenting or percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1999; 83:1326-9. [PMID: 10235089 DOI: 10.1016/s0002-9149(99)00094-6] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The Thrombolysis In Myocardial Infarction (TIMI) flow grade achieved in the infarct-related artery (IRA) during reperfusion therapy for acute myocardial infarction (AMI) is directly related to myocardial salvage. Recently, several series have demonstrated the safety of stenting in AMI and documented a larger postprocedure luminal diameter than that found at angioplasty, although no study has compared the effect of PTCA and stenting in AMI on flow characteristics of the IRA. The residual stenosis and the number of frames required to opacify standardized angiographic landmarks normalized for vessel length (corrected TIMI frame count) or compared with flow in a corresponding normal coronary artery (TIMI frame count index) were determined for the IRA of 39 patients who underwent angioplasty or stenting for AMI. Baseline characteristics were similar for the 20 patients who underwent stenting and the 19 patients who underwent percutaneous transluminal coronary angioplasty. After intervention, the luminal diameter was greater (3.24 vs 2.09 mm, p <0.0001) and the residual stenosis was less (-9.4% vs. 26.7%, p <0.0001) after stenting than after percutaneous transluminal coronary angioplasty. These changes in vessel geometry were associated with a lower corrected TIMI frame count (16.1 vs 30.7, p <0.002) and a lower TIMI frame count index (0.68 vs 1.3, p <0.002). Thus, stenting in AMI is associated with a greater postprocedure luminal diameter and improvement in coronary blood flow as measured by the TIMI frame count method.
Collapse
Affiliation(s)
- M E Edep
- University of California San Diego, USA
| | | | | | | | | |
Collapse
|
23
|
Abstract
BACKGROUND The purpose of this study was to provide an overview on stenting in acute myocardial infarction (MI). METHODS AND RESULTS A search of MEDLINE and the scientific sessions abstracts in peer review journals through May 1998 was carried out to identify any publications on stenting in MI. The settings were retrospective and prospective case series on stenting in MI, nonrandomized and randomized trials comparing primary stenting and primary percutaneous transluminal coronary angioplasty (PTCA) in MI, and stenting in cardiogenic shock complicating MI. Reported outcomes included procedural success, reocclusion, restenosis, and target vessel revascularization rates; incidence of death, MI, recurrent ischemia, major bleeding, and vascular complications; and incidence of cerebrovascular accidents. Procedural success rates were better for stenting than primary PTCA, and postprocedural minimum luminal diameters were larger. This resulted in lower reocclusion and restenosis rates and a lesser need for target vessel revascularization with primary stenting. The incidence of death, MI, and recurrent ischemia was also reduced with primary stenting. Major bleeding and vascular complications were confined to patients receiving anticoagulation as opposed to antiplatelet agents after stenting. Finally, a strategy of bailout stenting for failed PTCA in MI appears to be inferior to a primary stenting strategy. CONCLUSIONS Stenting in MI is an effective and safe reperfusion strategy with many advantages compared with primary PTCA.
Collapse
Affiliation(s)
- R H Mehta
- Division of Cardiology, University of Michigan Hospital, Ann Arbor, MI 48109, USA
| | | |
Collapse
|
24
|
Nakagawa Y, Matsuo S, Kimura T, Yokoi H, Tamura T, Hamasaki N, Nosaka H, Nobuyoshi M. Thrombectomy with AngioJet catheter in native coronary arteries for patients with acute or recent myocardial infarction. Am J Cardiol 1999; 83:994-9. [PMID: 10190508 DOI: 10.1016/s0002-9149(99)00003-x] [Citation(s) in RCA: 75] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
The AngioJet thrombectomy catheter removes thrombi by rheolytic fragmentation and suction. The purpose of this study was to identify the efficacy and safety of this new device. Myocardial infarction (MI) is associated with intracoronary thrombus. Intracoronary thrombus has been identified as a risk factor of unfavorable outcome after percutaneous transluminal coronary angioplasty. To what extent the AngioJet is applicable or effective for acute or recent MI in native coronary artery is not clear. Thrombectomy with the AngioJet was attempted in 31 patients with 31 native coronary arteries selected from 304 patients with acute or recent MI. Follow-up angiography was performed at 3 to 6 months. Procedure success was achieved in 29 patients (94%). Adjunctive balloon angioplasty was performed after AngioJet thrombectomy in 30 patients (97%), and in only 1 patient (3%) AngioJet thrombectomy was the sole procedure. Subsequent stenting after balloon angioplasty was attempted successfully in 12 patients (40%) without thrombotic complications. Thrombolysis In Myocardial Infarction trial flow grading increased from 0.70 +/- 0.97 before to 2.61 +/- 0.88 after AngioJet thrombectomy (p <0.0001), to 2.84 +/- 0.64 after adjunctive procedures (p = 0.070). At follow-up angiography restenosis rate was 21% but Thrombolysis In Myocardial Infarction flow 3 was present in all patients. The restenosis rate of stented patients was 8%. There were no major events during in-hospital and follow-up. The AngioJet can be used safely and successfully to remove thrombus from the native coronary artery of patients with MI. Thrombus removal makes subsequent stenting safe and uncomplicated. The restenosis rate was considered to be acceptable.
Collapse
Affiliation(s)
- Y Nakagawa
- Kokura Memorial Hospital, Kitakyushu, Japan
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Abstract
Coronary stenting has provided better results than balloon angioplasty in terms of primary success and restenosis in previous randomized studies. These studies only included short coronary lesions located in vessels larger than 3 mm. Thus, these results can not be applied to complex lesions or those located in small vessels. In the present article we summarize our points of view regarding the current indications of coronary stenting in these types of lesions, where the use of this device may be still controversial. In all these situations the results of the stent seem to be better to those previously reported with balloon angioplasty. However, there is a percentage of patients treated by balloon angioplasty in whom a good immediate and long-term result can be obtained. The identification of patients with optimal result after balloon angioplasty need a postprocedure study of coronary flow reserve. The comparison of optimal balloon angioplasty (by angiographic and coronary flow reserve criteria) and stent, is the main objective of 2 studies that are currently under process. We will have to wait the results of these clinical trials to answer to the question if the implant of stents in all kind of lesions located in vessel larger than 2.5 mm is of proper use. Our current opinion is that coronary stenting is a safe and fast method of coronary transcatheter therapy in many types of coronary lesions and it may be considered the more efficient technique of percutaneous revascularization.
Collapse
Affiliation(s)
- M Pan
- Servicio de Cardiología, Hospital Reina Sofía, Universidad de Córdoba.
| |
Collapse
|
26
|
Hsieh IC, Chang HJ, Chern MS, Hung KC, Lin FC, Wu D. Late coronary artery stenting in patients with acute myocardial infarction. Am Heart J 1998; 136:606-12. [PMID: 9778062 DOI: 10.1016/s0002-8703(98)70006-7] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
BACKGROUND The safety and efficacy of late coronary artery stenting of the infarct-related artery after acute infarction has not been evaluated previously. METHODS AND RESULTS Coronary artery stenting was performed in 117 consecutive patients with acute infarction who were receiving ticlopidine/aspirin regimen without coumarin. There were 97 men and 18 women, aged 58+/-11 (mean +/- SD) years. A total of 136 Palmaz-Schatz stents were successfully implanted in 130 lesions 15+/-8 days after acute myocardial infarction (median 9 days) in 115 of 117 (98%) patients. The minimal luminal diameter (MLD) increased from 0.66+/-0.46 to 3.14+/-0.53 mm (P< .001), with an acute gain of 2.49+/-0.61 mm. One patient had acute thrombosis requiring further stenting and another patient received emergency bypass surgery. There was no subacute thrombosis or other complications. During a follow-up duration of 14+/-3 months, 2 patients had angina pectoris develop and 1 died suddenly. Sixty-two patients underwent a follow-up coronary angiography 195+/-36 days after stenting. Restenosis was noted in 8 patients (13%); the MLD was 2.19+/-0.73 mm, the late loss was 0.96+/-0.65 mm (P< .001), the loss index was 0.39+/-0.28, and the net gain was 1.56+/-0.79 mm (P< .001). The angiographic left ventricular ejection fraction increased from 47%+/-12% to 55%+/-12% (P< .001). CONCLUSIONS Late coronary stenting of the infarct-related artery in patients with acute myocardial infarction is a safe and effective late reperfusion therapy and may be beneficial to the patients.
Collapse
Affiliation(s)
- I C Hsieh
- Department of Medicine, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan, Republic of China
| | | | | | | | | | | |
Collapse
|
27
|
NOBUYOSHI MASAKIYO, NAKAGAWA YOSHIHISA. Update on Extractional Thrombectomy Catheter, AngioJet? J Interv Cardiol 1998. [DOI: 10.1111/j.1540-8183.1998.tb00194.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
28
|
Himbert D, Juliard JM, Benamer H, Feldman LJ, Aubry P, Steg PG. Hospital outcome after bailout coronary stenting in patients with acute myocardial infarction. CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS 1998; 44:371-7. [PMID: 9716198 DOI: 10.1002/(sici)1097-0304(199808)44:4<371::aid-ccd1>3.0.co;2-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
We evaluated the outcome of bailout coronary stenting in acute myocardial infarction. Fifty patients (35 men, mean age 60 plusmn; 12) with acute myocardial infarction consecutively underwent bailout stenting after primary and rescue coronary angioplasty (n=41 and 9, respectively). Cardiogenic shock was present in six patients, and 17 others had contraindications to thrombolysis. Stent implantation was successful in 49/50 patients. The antithrombotic regimen combined heparin, aspirin, and ticlopidine. One patient had symptomatic stent closure. Predischarge angiography in 41/44 survivors showed widely patent stents in 40/41 patients. Six patients (4 of whom had been admitted with cardiogenic shock) died in the hospital. During acute myocardial infarction, bailout stenting can achieve high TIMI grade 3 coronary patency (here, 92%), and low acute stent closure rates (here, 2%). However, in-hospital mortality remained high, at nearly 10%, mainly due to the severe risk profile in this patient subset.
Collapse
Affiliation(s)
- D Himbert
- Department of Cardiology, University Hospital Bichat, Paris, France
| | | | | | | | | | | |
Collapse
|
29
|
Zaacks SM, Allen JE, Calvin JE, Schaer GL, Palvas BW, Parrillo JE, Klein LW. Value of the American College of Cardiology/American Heart Association stenosis morphology classification for coronary interventions in the late 1990s. Am J Cardiol 1998; 82:43-9. [PMID: 9671007 DOI: 10.1016/s0002-9149(98)00239-2] [Citation(s) in RCA: 48] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
The goal of this study was to reassess the accuracy of the American College of Cardiology/American Heart Association (ACC/AHA) stenosis morphology classification for predicting coronary intervention success and complications in the era of new devices. Previous studies performed in the early part of this decade for percutaneous transluminal coronary angioplasty in patients with multivessel coronary artery disease found that these criteria were predictive of success rates but not complication rates. Data for 957 consecutive coronary interventions in 1,404 lesions from June 1994 to October 1996 were prospectively classified according to ACC/AHA guidelines and entered into a database. Ninety-one and 9/10 of coronary interventions were successful, defined as <50% residual stenosis of each vessel attempted in the absence of major in-hospital complications, including Q-wave myocardial infarction, ventricular arrhythmia, need for emergency coronary artery bypass surgery, or death. Success rates did not differ between A (186 of 193, 96.3%), B1 (211 of 221, 95.5%), and B2 (676 of 711, 95.1%) lesions, but each was more successful than C (246 of 279, 88.2%) lesions (p <0.003, p < 0.004, and p = 0.0001, respectively). The class of lesion (A, B, or C) did not predict device (atherectomy, rotablator, and stent) use but specific morphologic characteristics of lesions within these classes were predictive of which device was used. Multiple regression analysis revealed that total occlusion and vessel tortuosity were predictive of procedure failure. Lesion type (A, B, or C) was not predictive of complications, but bifurcation lesions (p = 0.0045), presence of thrombus (p = 0.0001), inability to protect a major side branch (p = 0.0468), and degenerated vein graft lesions (p = 0.0283) were predictive. Thus, the ACC/AHA grading system is predictive of successful coronary intervention outcome, particularly of C-type characteristics, but not of complications or device success rate and selection. Although lesion type (A, B, or C) was not predictive of complications, specific lesion morphologies were predictive of adverse events and device use.
Collapse
Affiliation(s)
- S M Zaacks
- Rush-Presbyterian-St. Luke's Medical Center and Rush Heart Institute, Chicago, Illinois 60612, USA
| | | | | | | | | | | | | |
Collapse
|
30
|
Suryapranata H, van 't Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97:2502-5. [PMID: 9657469 DOI: 10.1161/01.cir.97.25.2502] [Citation(s) in RCA: 233] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Although the benefits of primary angioplasty in acute myocardial infarction have been demonstrated, several areas for improvement remain. Therefore, a prospective randomized trial comparing primary stenting with balloon angioplasty in patients with acute myocardial infarction was conducted. METHODS AND RESULTS Patients with acute myocardial infarction were randomly assigned to undergo either primary stenting (n=112) or balloon angioplasty (n=115). The clinical end points were death, recurrent infarction, subsequent bypass surgery, or repeat angioplasty of the infarct-related vessel. The overall mortality rate at 6 months was 2%. Recurrent infarction occurred in 8 patients (7%) after balloon angioplasty and in 1 (1%) after stenting (P=0.036). Subsequent target-vessel revascularization was necessary in 19 (17%) and 4 (4%) patients, respectively (P=0.0016). The cardiac event-free survival rate in the stent group was significantly higher than in the balloon angioplasty group (95% versus 80%; P=0.012). CONCLUSIONS In selected patients with acute myocardial infarction, primary stenting can be applied safely and effectively, resulting in a lower incidence of recurrent infarction and a significant reduction in the need for subsequent target-vessel revascularization compared with balloon angioplasty.
Collapse
Affiliation(s)
- H Suryapranata
- Department of Cardiology, Hospital De Weezenlanden, Zwolle, The Netherlands
| | | | | | | | | |
Collapse
|
31
|
Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Fazzini PF. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 1998; 31:1234-9. [PMID: 9581713 DOI: 10.1016/s0735-1097(98)00097-7] [Citation(s) in RCA: 237] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVES This study sought to compare stenting of the primary infarct-related artery (IRA) with optimal primary percutaneous transluminal coronary angioplasty (PTCA) with respect to clinical and angiographic outcomes of patients with an acute myocardial infarction. BACKGROUND Early and late restenosis or reocclusion of the IRA after successful primary PTCA significantly contributes to increased patient morbidity and mortality. Coronary stenting results in a lower rate of angiographic and clinical restenosis than standard PTCA in patients with angina and with previously untreated, noncomplex lesions. METHODS After successful primary PTCA, 150 patients were randomly assigned to elective stenting or no further intervention. The primary end point of the trial was a composite end point, defined as death, reinfarction or repeat target vessel revascularization as a consequence of recurrent ischemia within 6 months of randomization. The secondary end point was angiographic evidence of restenosis or reocclusion at 6 months after randomization. RESULTS Stenting of the IRA was successful in all patients randomized to stent treatment. At 6 months, the incidence of the primary end point was 9% in the stent group and 28% in the PTCA group (p=0.003); the incidence of restenosis or reocclusion was 17% in the stent group and 43% in the PTCA group (p=0.001). CONCLUSIONS Primary stenting of the IRA, compared with optimal primary angioplasty, results in a lower rate of major adverse events related to recurrent ischemia and a lower rate of angiographically detected restenosis or reocclusion of the IRA.
Collapse
Affiliation(s)
- D Antoniucci
- Division of Cardiology, Careggi Hospital, Florence, Italy.
| | | | | | | | | | | |
Collapse
|
32
|
Mahdi NA, Lopez J, Leon M, Pathan A, Harrell L, Jang IK, Palacios IF. Comparison of primary coronary stenting to primary balloon angioplasty with stent bailout for the treatment of patients with acute myocardial infarction. Am J Cardiol 1998; 81:957-63. [PMID: 9576153 DOI: 10.1016/s0002-9149(98)00072-1] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
This study compares the immediate and long-term outcomes of a primary coronary stenting strategy with primary balloon angioplasty with stent bailout in the treatment of patients with acute myocardial infarction (AMI). One hundred forty-seven consecutive patients who underwent primary balloon angioplasty with stent bailout (n = 94) or primary stenting (n = 53) for AMI were clinically followed for 8.1 +/- 5.7 and 8.5 +/- 4.5 months, respectively. Immediate results, as well as in-hospital and long-term ischemic events (death, reinfarction, and repeat revascularization) were compared between both groups. Angiographic success was 91.5% in the balloon angioplasty group and 94% in the stent group. In-hospital and late follow-up combined ischemic events were 22 of 94 (23%) versus 0 of 53 (0%); p < 0.001 and 33 of 78 (42%) versus 13 of 53 (25%), p = 0.04 for the balloon angioplasty and stent groups, respectively. At 6 months, the cumulative probability of repeat target lesion revascularization was higher in the balloon angioplasty group (47% vs 18%, p = 0.0006) as was the probability of late target revascularization (36% vs 18%, p = 0.046); the cumulative event-free survival after 6 months was significantly lower in the balloon angioplasty group (44% vs 80%, p = 0.0001). This study demonstrates that a primary stent placement strategy in patients with AMI is safe, feasible, and superior to primary balloon angioplasty with stent bailout. Primary stenting results in a larger postprocedural minimal luminal diameter, a lower early and late recurrent ischemic event rate, and a lower incidence of target lesion revascularization at follow-up.
Collapse
Affiliation(s)
- N A Mahdi
- Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
| | | | | | | | | | | | | |
Collapse
|
33
|
Le May MR, Labinaz M, Marquis JF, O'Brien ER, Beanlands RS, Laramée LA, Williams WL, Davies RF, Kearns SA, Higginson LA. Late clinical and angiographic follow-up after stenting in evolving and recent myocardial infarction. Am Heart J 1998; 135:714-8. [PMID: 9539491 DOI: 10.1016/s0002-8703(98)70291-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVES This study sought to assess the late clinical and angiographic outcomes of patients who received stents within the first week of acute myocardial infarction (AMI). BACKGROUND Recent studies have demonstrated that stenting of the infarct-related artery is a useful adjunct to balloon angioplasty in patients with AMI. However, there are limited data on the late clinical and angiographic outcomes of these patients. METHODS Between January 1994 and September 1995, 32 patients at our institution underwent stenting of the infarct-related artery within 1 week of AMI: 13 within 14 hours (evolving group) and 19 between days 2 and 7 (recent AMI group). Late clinical follow-up was obtained on all survivors. Quantitative angiographic measurements were recorded on the stented segments before stenting, immediately after stenting, and on the follow-up angiograms. RESULTS At 13.1+/-6.4 months from the time of stenting, three patients died and three required repeat angioplasty, but no patient had reinfarction or required bypass surgery. At follow-up 26 (81%) of 32 patients remained free of major cardiac events; of these, 24 (92%) were free of angina. Repeat angiography performed at 10.8+/-7.5 months in 26 (87%) of 30 discharged patients showed that all infarct-related arteries were patent and the restenosis rate was low: 22% in the 13 patients with evolving AMI (<14 hours) and 12% in the 19 patients with recent AMI (days 2 through 7). CONCLUSION In this study stenting of the infarct-related artery in patients with evolving and recent AMI was associated with a favorable late clinical outcome. Patency of the infarct-related artery was well maintained, and the restenosis rate was low.
Collapse
Affiliation(s)
- M R Le May
- Division of Cardiology at the University of Ottawa Heart Institute, Ontario, Canada
| | | | | | | | | | | | | | | | | | | |
Collapse
|
34
|
Nakagawa Y, Matsuo S, Yokoi H, Tamura T, Kimura T, Hamasaki N, Nosaka H, Nobuyoshi M. Stenting after thrombectomy with the AngioJet catheter for acute myocardial infarction. CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS 1998; 43:327-30. [PMID: 9535376 DOI: 10.1002/(sici)1097-0304(199803)43:3<327::aid-ccd20>3.0.co;2-h] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The presence of massive intracoronary thrombi may contraindicate stenting. The AngioJet catheter rheolytic thrombectomy prepared the road for an easy and uneventful stenting in 2 patients with acute myocardial infarction (AMI) and thrombi. This combination provides a promising strategy for patients with AMI and angiographic evidence of massive thrombi.
Collapse
Affiliation(s)
- Y Nakagawa
- Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Antoniucci D, Valenti R, Santoro GM, Bolognese L, Trapani M, Moschi G, Fazzini PF. Systematic direct angioplasty and stent-supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: in-hospital and long-term survival. J Am Coll Cardiol 1998; 31:294-300. [PMID: 9462570 DOI: 10.1016/s0735-1097(97)00496-8] [Citation(s) in RCA: 114] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
OBJECTIVES This prospective observational study was conducted to examine the apparent impact of a systematic direct percutaneous transluminal coronary angioplasty (PTCA) strategy on mortality in a series of 66 consecutive patients with acute myocardial infarction (AMI) complicated by cardiogenic shock, and to analyze the predictors of outcome after successful direct PTCA. BACKGROUND Previous studies have reported encouraging results with PTCA in patients with AMI complicated by cardiogenic shock, but a biased case selection for PTCA may have heavily influenced the observed outcomes. METHODS All patients admitted with AMI were considered eligible for direct PTCA, including those with the most profound shock, and no upper age limit was used. The treatment protocol also included stenting of the infarct-related artery for a poor or suboptimal angiographic result after conventional PTCA. RESULTS Between January 1995 and March 1997, 364 consecutive patients underwent direct PTCA, and in 66 patients AMI was complicated by cardiogenic shock. In patients with cardiogenic shock, direct PTCA had a success rate of 94%; an optimal angiographic result was achieved in 85%; primary stenting of the infarct-related artery was accomplished in 47%; and the in-hospital mortality rate was 26%. Univariate analysis showed that patient age, chronic coronary occlusion and completeness of revascularization were significantly related to in-hospital mortality. The mean follow-up period was 16 +/- 8 months. Survival rate at 6 months was 71%. Comparison of event-free survival in patients with a stented or nonstented infarct-related artery suggests an initial and long-term benefit of primary stenting. CONCLUSIONS Systematic direct PTCA, including stent-supported PTCA, can establish a Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow in the great majority of patients presenting with AMI and early cardiogenic shock. High performance criteria, including new devices such as coronary stents, should be considered in randomized trials where mechanical revascularization therapy is being tested.
Collapse
Affiliation(s)
- D Antoniucci
- Division of Cardiology, Careggi Hospital, Florence, Italy.
| | | | | | | | | | | | | |
Collapse
|
36
|
Antonellis IP, Patsilinakos SP, Pamboukas CA, Kranidis AJ, Margaris NG, Kostopoulos C, Tavernarakis AG, Rokas SG. Stent implantation in patient with visible intracoronary thrombus and compromised left ventricular function, after local thrombolysis using the Dispatch catheter. Int J Cardiol 1998; 63:75-80. [PMID: 9482148 DOI: 10.1016/s0167-5273(97)00258-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The case of a patient with unstable angina and angiographic findings of significant (approximately 90%) right coronary artery stenosis with an intracoronary thrombus next to the lesion, total left anterior descending and circumflex occlusion and an ejection fraction of approximately 22% is described. The case was treated with stent implantation after local thrombolysis with the use of the Dispatch infusion catheter.
Collapse
Affiliation(s)
- I P Antonellis
- Invasive Cardiology Unit, Evangelismos Hospital, Athens, Greece
| | | | | | | | | | | | | | | |
Collapse
|
37
|
La angioplastia primaria es la terapéutica de reperfusión de elección en el tratamiento del infarto agudo de miocardio. Argumentos a favor. Rev Esp Cardiol 1998. [DOI: 10.1016/s0300-8932(98)74845-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
38
|
Klues HG, Radke PW, Hoffmann R, vom Dahl J. [Pathophysiology and therapeutic concepts in coronary restenosis]. Herz 1997; 22:322-34. [PMID: 9483438 DOI: 10.1007/bf03044283] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Demonstration of a reduced restenosis rate after stent implantation (Benestent, STRESS) has initiated rapid increase in stent implantation rates with widening indications. At present, the majority of stents are implanted in "none-Benestent/STRESS-lesions" with the consequence of a higher restenosis rate as previously expected. Stent restenosis has therefore become a relevant problem in interventional cardiology. In contrast to balloon angioplasty, where acute and subacute recoil represents the major mechanism of restenosis, stent restenosis is exclusively attributed to neointima proliferation. Morphological studies have demonstrated that neointima is caused by early smooth muscle cell ingrowth with a maximum after 7 days which is then gradually replaced by extracellular matrix. Systematic clinical, angiographic and intravascular ultrasound studies have identified several risk factors for increased stent restenosis such as: diabetes mellitus, treatment of restenosis, serial stent implantation, small and calcified vessels, ostial lesions, venous bypass grafts and complex stenosis morphology. In addition, there is increasing evidence that aggressive implantation techniques with high pressures and oversized balloons may also induce higher restenosis rates. Optimal treatment of instent restenosis has not been determined so far. Balloon angioplasty is at present considered the therapeutic option of choice. Several small studies have shown, that in short, discrete lesions (< 10 mm) results of simple PTCA are acceptable with re-restenosis rates between 15 and 35%. The intervention is considered safe with low complication rates. In 10 to 15% additional stent implantation is necessary, usually due to dissections proximal or distal to the treated stent. In long, diffuse stent restenosis (> or = 10 mm), however, PTCA results in high re-restenosis rates up to > 80%. This is most likely due to insufficient early balloon angioplasty results with minimal luminal diameters (MLD) significantly below the previous stent diameter. Therefore, debulking techniques have been used to reduce neointima burden within the stent. At present 3 techniques are available: directional coronary atherectomy (DCA), Excimerlaser angioplasty (ELCA) or high frequency rotablation. All of these techniques achieve a significant reduction in plaque volume within the stent and in combination with balloon angioplasty allow larger MLDs than PTCA alone. Limited experiences with ELCA and rotablation have shown that the techniques are safe without major periinterventional complications. DCA, however, has been accompanied with stent destruction and therefore should be considered with large care, especially in stents with coil design. At present, no randomized controlled trials for the comparison of debulking techniques with or without balloon angioplasty versus balloon angioplasty alone are available. Three multicenter trials have been initiated (LARS, ARTIST and TWISTER) to compare debulking techniques versus balloon angioplasty in diffuse stent restenosis. Adjunct medical treatment after interventions for stent restenosis is usually limited to ASS alone, indications for additional application of Ticlopidine have not been verified so far. Positive results are expected for the use of local radiation therapy either by radioactive stent implantation or afterloading techniques. With increasing stent implantation rates and indications, about 400,000 stents will be implanted in 1997 worldwide. Considering a low restenosis rate of 20%, 80,000 stent restenosis will occur within one year. Final recommendations for optimal treatment of these patients are not yet available.
Collapse
Affiliation(s)
- H G Klues
- Medizinische Klinik I, Universitätsklinikum der RWTH Aachen.
| | | | | | | |
Collapse
|
39
|
Juergens CP, Whitbourn RJ, Yeung AC, Oesterle SN. Primary angioplasty for acute myocardial infarction. Vasc Med 1997; 2:327-34. [PMID: 9575607 DOI: 10.1177/1358863x9700200409] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The use of thrombolytic therapy has been widely accepted for the treatment of acute myocardial infarction. Despite improving mortality, thrombolytic therapy may be contraindicated in many patients presenting with myocardial infarction and is associated with a small, yet significant risk of hemorrhagic sequelae. This article outlines the rationale behind reperfusion therapy, the use of pharmacological thrombolysis and the role of adjunctive angioplasty. The potential advantages of a therapeutic strategy of primary angioplasty, instead of thrombolysis, are discussed. These include anatomical definition, risk stratification, reduced recurrent ischemia, enhanced coronary perfusion and improved coronary patency. The randomized trials in which primary angioplasty and thrombolytic therapy were compared are reviewed. We conclude that angioplasty results in a reduction of short-term mortality and nonfatal reinfarction and therefore advocate the routine use of coronary angioplasty as a primary reperfusion strategy for acute myocardial infarction. The potential limitations of primary angioplasty in the community hospital setting are discussed. Finally, we examine the roles of adjunctive mechanical (e.g. stents) and pharmacological (e.g. Abciximab) means of further enhancing outcomes after primary angioplasty.
Collapse
Affiliation(s)
- C P Juergens
- Division of Cardiovascular Medicine, Stanford University Medical Center, CA 94305, USA
| | | | | | | |
Collapse
|
40
|
Monassier JP, Hamon M, Elias J, Maillard L, Spaulding C, Raynaud P, Cribier A, Barragan P, Juliard JM, Lefevre T, Aubry P, Faugier JP, Masquet C, Rioux P, Bedossa M, Joly P, Petiteau PY, Royer T, Morice MC, Roriz R, Cattan S, Meyer P, Blanchard D, Khalifé K. Early versus late coronary stenting following acute myocardial infarction: results of the STENTIM I Study (French Registry of Stenting in Acute Myocardial Infarction). CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS 1997; 42:243-8. [PMID: 9367093 DOI: 10.1002/(sici)1097-0304(199711)42:3<243::aid-ccd1>3.0.co;2-c] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
This study was undertaken to determine the feasibility and safety of coronary stenting in acute myocardial infarction (AMI). In AMI, primary percutaneous transluminal coronary angioplasty (PTCA) is accepted as the preferred method of reperfusion for patients presenting at highly experienced centres. Until recently, however, stenting has been avoided during AMI because of a potential high risk of thrombosis. This prospective observational study carried out in 20 centres and included 648 consecutive patients who underwent PTCA with stent implantation for AMI. Of these 648 patients, 269 (41.5%, Group 1) were dilated early (< 24 hr) after the onset of the symptoms (75% treated by direct PTCA) and 379 (58.5%, Group 2) were dilated between 24 hr and 14 days after AMI. Combined therapy with ticlopidin and aspirin was used after the procedure. Bailout stenting occurred more often in Group 1 than in Group 2 (17% vs. 9.5%)(P < 0.05). Angiographic successful stenting was similar in both groups of patients (96% vs. 97%). During the hospital follow-up period, stent thrombosis occurred in eight patients (3%) in Group 1 and in six patients (1.6%) in Group 2 (NS). There was 14 deaths (5.2%) in Group 1 and 11 deaths (3.9%) in Group 2 (NS). After multivariate analysis bailout stenting was identified as the sole predictor of stent thrombosis (P < 0.0001). Vascular access-site complications occurred in six patients (1%) with no difference between the two groups. This study indicates that patients who receive a coronary stent in AMI can be managed safely with antiplatelet therapy. Randomized studies are needed to determine the precise indication for coronary stenting as an adjunct to primary PTCA.
Collapse
Affiliation(s)
- J P Monassier
- Unité de Pathologie Coronaire et de Cardiologie Interventionnelle, Hôpital Emile Muller, Mulhouse, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Murdock DK, Logemann T, Hoffmann MT, Olson KJ, Engelmeier RS. Coronary artery stenting for suboptimal PTCA results in acute myocardial infarction in patients treated with Abciximab: early and six-month outcome. CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS 1997; 42:173-9. [PMID: 9328702 DOI: 10.1002/(sici)1097-0304(199710)42:2<173::aid-ccd16>3.0.co;2-p] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Emergent percutaneous transluminal coronary angioplasty (PTCA) is an effective treatment for acute myocardial infarction. However, occasionally results of angioplasty are suboptimal due to coronary dissection or elastic recoil, leading to a high chance of recurrent ischemia. Coronary stents are occasionally employed in such settings, but a high incidence of stent thrombosis was noted by early investigators when stents were placed into areas of active thrombus formation. Since coronary thrombosis and stent thrombosis are both initiated by platelets, the potent antiplatelet agent abciximab might be useful in preventing stent thrombosis. Little information is available concerning early outcome or 6-month clinical event rate when coronary artery stents are placed for suboptimal angioplasty results for acute myocardial infarction in patients given abciximab. We deployed 75 stents as part of angioplasty for acute myocardial infarction in 40 patients given abciximab. All patients had suboptimal angioplasty results leading to stent deployment. Each obtained normal flow angiographically and no stent thrombosis or acute closure was observed. Early mortality occurred in 1 patient. All patients were followed at least 6 months, and no patient died after hospital discharge. Three patients experienced recurrent ischemic events within the first 6 months. Two of these events were due to infarct vessel restenosis. We conclude the combined use of coronary artery stents and abciximab for suboptimal PTCA results during acute myocardial infarction is associated with a low incidence of culprit vessel recurrent ischemic events within 6 months of intervention.
Collapse
Affiliation(s)
- D K Murdock
- Cardiovascular Associates of Northern Wisconsin, Wausau, USA
| | | | | | | | | |
Collapse
|
42
|
Juliard JM, Himbert D, Golmard JL, Aubry P, Karrillon GJ, Boccara A, Benamer H, Steg PG. Can we provide reperfusion therapy to all unselected patients admitted with acute myocardial infarction? J Am Coll Cardiol 1997; 30:157-64. [PMID: 9207637 DOI: 10.1016/s0735-1097(97)00119-8] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVES This study sought to assess the maximal rate of acute Thrombolysis in Myocardial Infarction (TIMI) grade 3 patency that can be achieved in unselected patients. BACKGROUND Early and complete (TIMI grade 3 flow) reperfusion is an important therapeutic goal during acute myocardial infarction. However, thrombolysis, although widely used, is often contraindicated or ineffective. The selective use of primary and rescue percutaneous transluminal coronary angioplasty (PTCA) may increase the number of patients receiving reperfusion therapy. METHODS A cohort of 500 consecutive unselected patients with acute myocardial infarction were prospectively treated using a patency-oriented scheme: Thrombolysis-eligible patients received thrombolysis (n = 257) and underwent 90-min angiography to detect persistent occlusion for treatment with rescue PTCA. Emergency PTCA (n = 193) was attempted in patients with contraindications to thrombolysis, cardiogenic shock or uncertain diagnosis and in a subset of patients admitted under "ideal conditions." A small group of patients (n = 38) underwent acute angiography without PTCA. Conventional medical therapy was used in 12 patients with contraindications to both thrombolysis and PTCA. RESULTS Ninety-eight percent of patients received reperfusion therapy (thrombolysis, PTCA or acute angiography), and angiographically proven early TIMI grade 3 patency was achieved in 78%. Among patients with TIMI grade 3 patency, thrombolysis alone was the strategy used in 37%, emergency PTCA in 40% and rescue PTCA after failed thrombolysis in 15%; spontaneous patency occurred in 8%. CONCLUSIONS Reperfusion therapy can be provided to nearly every patient (98%) with acute myocardial infarction. Rescue and direct PTCA provided effective early reperfusion to patients in whom thrombolysis failed or was excluded.
Collapse
Affiliation(s)
- J M Juliard
- Cardiology Department, Hôpital Bichat, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
43
|
Spaulding C, Cador R, Benhamda K, Ali OS, Garcia-Cantu E, Monsegu J, Py A, Weber S. One-week and six-month angiographic controls of stent implantation after occlusive and nonocclusive dissection during primary balloon angioplasty for acute myocardial infarction. Am J Cardiol 1997; 79:1592-5. [PMID: 9202346 DOI: 10.1016/s0002-9149(97)00204-x] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
We prospectively assessed in 124 consecutive patients by means of 1-week and 6-month follow-up angiograms the rate of reocclusion and restenosis of coronary stenting with Palmaz-Schatz stents after occlusive and nonocclusive dissection during primary balloon angioplasty for acute myocardial infarction (AMI). Patients were further evaluated clinically at 1 year. Stenting was performed on large (>3.2 mm) coronary arteries for suboptimal results (47%), occlusive (8%), or nonocclusive dissections (45%) after balloon angioplasty. Stents were delivered using the bare stent technique and high pressure inflations (>12 atm). All patients received ticlopidine 250 mg (500 mg if weight was >80 kg) and aspirin 100 mg for 1 month. No patient received warfarin. At 1 week, 6 patients died of cardiogenic shock and 2 of right ventricular infarction. One subacute occlusion occurred at day 14. At 6 months, in 95 patients, the angiographic restenosis rate (>50% diameter stenosis) was 19%. One-year clinical follow-up, available in 55 patients, indicated cardiac death in 5, and repeat revascularization in 3. Thus, coronary stenting on large (>3.2 mm) coronary arteries after occlusive and nonocclusive dissection during primary balloon angioplasty for AMI using bare Palmaz-Schatz stents, high pressures, ticlopidine, and aspirin is safe. Our reocclusion and restenosis rates are similar to those of trials on elective stenting in stable patients.
Collapse
Affiliation(s)
- C Spaulding
- Cardiology Department, Cochin Hospital, Rene Descartes University, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Zahn R, Schneider M, Schuster S, Seidl K, Isgro F, Werling C, Senges J. [Direct dilatation and emergency bypass operation of main branch occlusion in acute anterior wall infarct and cardiogenic shock]. Herz 1997; 22:111-5. [PMID: 9206704 DOI: 10.1007/bf03044310] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Occlusion of the left main coronary artery (LMCA) is the cause of myocardial infarction in about 0.04%. Those patients who do not die during the acute phase often do have a dominant right coronary artery with extensive collaterals to the left coronary artery. Because this is a very rare situation there are only some cases reports dealing with the management of these patients. A 60 years old woman was admitted to our hospital with the signs of an acute Q-wave anterior myocardial infarction. Within a few minutes after the arrival she developed a cardiogenic shock. Coronary angiography was performed immediately. The left main coronary artery was occluded and a big right coronary artery showed a significant stenosis. There were many collaterals from the right coronary artery supplying the left coronary artery. After information of the cardiac surgeons, primary angioplasty of the LMCA was performed in order to achieve hemodynamic stabilisation and to relieve symptoms. Reperfusion of the left anterior descendent coronary artery (LAD) could be achieved within 30 minutes. This led to hemodynamic stabilisation of the patient. But a significant residual stenosis of the LMCA remained and the circumflex artery was still occluded. In the meanwhile cardiac surgery was able to be performed and so the patient was transferred to surgery without further dilatation or stent implantation. Four venous grafts (LAD, first diagonal branch, circumflex artery and right coronary artery) were inserted. After 4 weeks the patient was in a good shape and could be discharged at home. Primary angioplasty seems to be an effective treatment in patients with acute myocardial infarction and an occlusion of the LMCA. But coronary bypass surgery is nearly almost necessary during the following period in order to achieve complete revascularisation and to improve survival.
Collapse
|
45
|
Alfonso F, Rodriguez P, Phillips P, Goicolea J, Hernández R, Pérez-Vizcayno MJ, Fernández-Ortiz A, Segovia J, Bañuelos C, Aragoncillo P, Macaya C. Clinical and angiographic implications of coronary stenting in thrombus-containing lesions. J Am Coll Cardiol 1997; 29:725-33. [PMID: 9091516 DOI: 10.1016/s0735-1097(96)00566-9] [Citation(s) in RCA: 62] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVES This study sought to determine the results of coronary stenting in thrombus-laden lesions. BACKGROUND The angiographic evidence of intracoronary thrombus has classically been considered a formal contraindication to stent implantation. However, with increasing use of stenting, the indications for this technique have widened to include treatment of patients who have an acute coronary syndrome or lesions with adverse anatomic features. METHODS We studied 86 consecutive patients (mean age +/- SD 61 +/- 11 years, 14 women) undergoing coronary stenting of a thrombus-containing lesion; the procedure was performed electively in 39% and after angioplasty failure in 61%. Sixty-four patients (75%) were treated for unstable angina, and 19 (22%) underwent the procedure during an acute myocardial infarction. A specific protocol that included clinical and late angiographic follow-up was used. RESULTS Angiographic success was obtained in 83 patients (96%). Five patients (6%) died during the hospital stay despite angiographic success; four of these had cardiogenic shock, and one (1%) had subacute stent thrombosis. Non-Q wave myocardial infarction developed in five additional patients (6%), and four of these five had data consistent with distal embolization. Of the 78 patients discharged with angiographic success, 67 (86%) were event-free and clinically improved at last follow-up visit (12 +/- 11 months). During the follow-up period, eight patients required repeat angioplasty, one patient required heart transplantation, and two patients died. Quantitative angiography demonstrated excellent angiographic results after stenting (minimal lumen diameter 0.31 +/- 0.4 vs. 2.77 +/- 0.6 mm). Late angiographic follow-up (5.5 +/- 1 months) was obtained in 50 patients with 54 lesions (93% of eligible), revealing a minimal lumen diameter of 2.0 +/- 1 mm and restenosis (lumen narrowing > 50%) in 18 lesions (33%). CONCLUSIONS Coronary stenting constitutes an effective therapeutic strategy for patients with thrombus-containing lesions, either after failure of initial angioplasty or electively as the primary procedure. Coronary stenting in this adverse anatomic setting results in a high degree of angiographic success, a low incidence of subacute thrombosis and an acceptable restenosis rate.
Collapse
Affiliation(s)
- F Alfonso
- Interventional Cardiology Unit, Hospital Universitario San Carlos, Madrid, Spain
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Schömig A, Neumann FJ, Walter H, Schühlen H, Hadamitzky M, Zitzmann-Roth EM, Dirschinger J, Hausleiter J, Blasini R, Schmitt C, Alt E, Kastrati A. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. J Am Coll Cardiol 1997; 29:28-34. [PMID: 8996291 DOI: 10.1016/s0735-1097(96)00450-0] [Citation(s) in RCA: 99] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
OBJECTIVES The Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial is a randomized comparison of combined antiplatelet with anticoagulant therapy after coronary Palmaz-Schatz stent placement. The objective of this study was to compare early and late clinical and angiographic outcome in a subgroup of patients with stent placement for acute myocardial infarction. BACKGROUND Stenting has become a treatment option for acute myocardial infarction, but it is not known which antithrombotic regimen is more adequate after stent implantation. METHODS One hundred twenty-three patients with successful stenting after acute myocardial infarction were randomized to receive aspirin plus ticlopidine (n = 61) or intense anticoagulant therapy (n = 62). Six-month repeat angiography was performed in 101 (86.3%) eligible patients. RESULTS During the first 30 days after stenting, patients with antiplatelet therapy had a significantly lower clinical event rate (3.3% vs. 21.0%, p = 0.005) and stent vessel occlusion rate (0% vs. 9.7%, p = 0.03) and a trend to fewer cardiac events (1.6% vs. 9.7%, p = 0.12). After 6 months, the survival rate free of recurrent myocardial infarction was higher in patients with antiplatelet therapy (100% vs. 90.3%, p = 0.03), and the rate of stent vessel occlusion was lower (1.6% vs. 14.5%, p = 0.02). Both groups had comparable restenosis rates (26.5% vs. 26.9%, p = 0.87). CONCLUSIONS This study demonstrates that combined antiplatelet therapy after stent placement in patients with acute myocardial infarction is associated with an overall better clinical and angiographic outcome than anticoagulant therapy.
Collapse
Affiliation(s)
- A Schömig
- 1. Medizinische Klinik, Klinikum rechts der Isar, Munich, Germany
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Webb JG, Carere RG, Hilton JD, Rabinowitz A, Buller E, Dodek AA, Abel J. Usefulness of coronary stenting for cardiogenic shock. Am J Cardiol 1997; 79:81-4. [PMID: 9024744 DOI: 10.1016/s0002-9149(96)00683-2] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Coronary stenting was performed in 15 selected patients with cardiogenic shock, with favorable clinical and angiographic outcomes. This experience suggests that coronary stenting may play an important adjunctive role in the management of cardiogenic shock and may improve outcome beyond that achieved with balloon angioplasty alone.
Collapse
Affiliation(s)
- J G Webb
- Department of Medicine, St. Paul's Hospital, University of British Columbia, Vancouver, Canada
| | | | | | | | | | | | | |
Collapse
|
48
|
el Setiha M, el Gamal M, Koolen J, Pijls N, Bonnier H, Michels R. Coronary stenting for failed angioplasty in acute myocardial infarction. CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS 1996; 39:149-54. [PMID: 8922315 DOI: 10.1002/(sici)1097-0304(199610)39:2<149::aid-ccd8>3.0.co;2-f] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
UNLABELLED Intracoronary stents were implanted in 15 patients after unsuccessful PTCA in the setting of acute myocardial infarction (AMI). The stented vessel was the left anterior descending (LAD) in 11 patients, the right coronary artery (RCA) in 3 patients, and a venous bypass graft to the LAD in a single patient. A total of 16 stents were implanted (15 Palmaz Schatz, Johnson and Johnson; and 1 Wiktor, Medtronic). FOLLOW-UP 1 patient died 10 days after stent implantation as a result of renal failure and cardiogenic shock. Subacute thrombosis occurred in 2 patients, 5 and 15 days after stent implantation; both underwent successful emergency coronary artery bypass grafting (CABG). The remaining 12 patients were free from major ischemic events (death, AMI, and further revascularization) after a mean follow-up of 18.7 +/- 4.1 months. We conclude that the long-term results of intracoronary stenting in AMI after failed PTCA are favourable.
Collapse
Affiliation(s)
- M el Setiha
- Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands
| | | | | | | | | | | |
Collapse
|